 | CD30, also known as TNFRSF8 (TNF receptor superfamily member 8), is a cell membrane protein of the tumor necrosis factor receptor family and a tumor marker... 13 KB (1,665 words) - 03:34, 21 December 2023 |
CD153 (redirect from CD30 ligand) receptor CD30. It plays a role in the T cell-dependent anti-mycobacterial immune response. Marín ND, García LF (January 2017). "The role of CD30 and CD153... 1 KB (102 words) - 02:09, 28 March 2022 |
non-Hodgkin lymphoma. It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL. The drug is being... 21 KB (1,998 words) - 19:56, 17 March 2024 |
treat cancer. Brentuximab vedotin, for example, links the chimeric anti-CD30 monoclonal antibody (cAC10) via a protease-cleavable linker to MMAE. This... 34 KB (3,140 words) - 06:38, 13 March 2024 |
 | is a CD30-targeting antibody that delivers a toxin, monomethyl auristatin E, to CD30-expressing cells, has therapeutic efficacy against other CD30-expressing... 69 KB (8,143 words) - 18:36, 22 January 2024 |
 | kidney-shaped or horseshoe-shaped nuclei, prominent Golgi, and express the CD30 tumor marker protein on their surface membranes. In 2016, the World Health... 41 KB (5,218 words) - 01:14, 29 February 2024 |
Primary cutaneous CD-30 positive T-cell lymphoproliferative disorders (redirect from CD30+ cutaneous T-cell lymphoma) cutaneous CD30+ large cell lymphoma List of cutaneous conditions Shinohara, Michi M.; Shustov, Andrei (August 8, 2019). "How I treat primary cutaneous CD30+ lymphoproliferative... 2 KB (90 words) - 20:36, 26 January 2024 |
large cell lymphoma belongs to the group of cutaneous processes that are CD30+ lymphoproliferative and are characterized by autoregressive, recurrent,... 10 KB (843 words) - 21:31, 23 January 2024 |
 | antibodies (usually forming an antibody-drug conjugate). targeting the protein CD30 which is found on malignant cells in anaplastic large cell lymphoma and Hodgkin's... 9 KB (649 words) - 22:01, 12 August 2023 |
 | disease, skin erythema and peripheral blood involvement Primary cutaneous CD30-positive T cell lymphoproliferative disorders Primary cutaneous anaplastic... 68 KB (6,701 words) - 20:31, 23 April 2024 |